Formulation and evaluation of matrix type mucoadhesive tablets aimed at treating oral aphtha

Drug Development and Industrial Pharmacy

Volumn 39, Issue 8, 2013, Pages 1254-1261

  Ikeuchi Takahashi, Yuri ^a   Watanabe, Naoko ^b   Sasatsu, Masanaho ^a   Onishi, Hiraku ^a  

^a HOSHI UNIVERSITY   (Japan)

^b NIHON PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Buccal; Controlled release; Formulation; Mucosal delivery; Physicochemical properties; Polymers; Solid dosage form; X ray powder diffractometry

Indexed keywords

CARBOMER; ETHYL CELLULOSE; ETHYL CELLULOSE 10; ETHYL CELLULOSE 45; FAT; INDOMETACIN; POLYMER; UNCLASSIFIED DRUG; WATER; XANTHAN;

APHTHOUS STOMATITIS; ARTICLE; CHEMICAL COMPOSITION; CHEMICAL MODIFICATION; CONTROLLED STUDY; DRUG EFFICACY; DRUG SOLUBILITY; IN VITRO STUDY; MUCOADHESION; SUSPENSION; SUSTAINED DRUG RELEASE; TABLET FORMULATION; TENSILE STRENGTH;

ADHESIVENESS; ALGINATES; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CALORIMETRY, DIFFERENTIAL SCANNING; CHEMISTRY, PHARMACEUTICAL; DELAYED-ACTION PREPARATIONS; GLUCURONIC ACID; HEXURONIC ACIDS; HUMANS; INDOMETHACIN; MOUTH MUCOSA; SOLUBILITY; STOMATITIS, APHTHOUS; TABLETS; TENSILE STRENGTH; X-RAY DIFFRACTION;

EID: 84879972398     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.3109/03639045.2012.717297     Document Type: Article

References (38)

1. Sonis S, Treister N, Chawla S, Demetri G, Haluska F. (2010). Preliminary characterization of oral lesions associated with inhibitors of mammalian target of rapamycin in cancer patients. Cancer, 116:210-215.
2. Mizrahi B, Golenser J, Wolnerman JS, Domb AJ. (2004). Adhesive tablet efective for treating canker sores in humans. J Pharm Sci, 93:2927-2935.
3. Momo K, Homma M, Kambayashi Y, Kohda Y. Indomethacin-spray preparation for oral mucositis caused by anti-cancer treatment. J Pharm Sci Technol 2012;72:15-19.
4. Kutcher MJ, Ludlow JB, Samuelson AD, Campbell T, Pusek SN. (2001). Evaluation of a bioadhesive device for the management of aphthous ulcers. J Am Dent Assoc, 132:368-376.
5. Momo K, Shiratsuchi T, Taguchi H, Hashizaki K, Saito Y, Makimura M et al. (2005). Preparation and clinical application of indomethacin gel for medical treatment of stomatitis. Yakugaku Zasshi, 125:433-440.
6. Nakamura T, Aoyama T, Yanagihara Y, Yamada Y, Miyoshi A, Kanda Y et al. (2003). [Te efects of indomethacin spray on the pain of stomatitis in the patients for hematopoietic stem cell transplantation]. Yakugaku Zasshi, 123:1023-1029.
7. Takeuchi K, Watanabe M, Yanagi M, Murakami I, Hosono H, Nishizawa S et al. (2008). In-vitro and clinical evaluation of an oral mucosal adhesive flm containing indomethacin. Yakugaku Zasshi, 128:1791-1795.
8. Ceschel GC, Mafei P, Lombardi Borgia S, Ronchi C. (2001). Design and evaluation of buccal adhesive hydrocortisone acetate (HCA) tablets. Drug Deliv, 8:161-171.
9. Nicolazzo JA, Reed BL, Finnin BC. (2005). Enhancing the buccal mucosal uptake and retention of triamcinolone acetonide. J Control Release, 105:240-248.
10. Shin SC, Bum JP, Choi JS. (2000). Enhanced bioavailability by buccal administration of triamcinolone acetonide from the bioadhesive gels in rabbits. Int J Pharm, 209:37-43.
11. Shin SC, Kim JY. (2000). Enhanced permeation of triamcinolone acetonide through the buccal mucosa. Eur J Pharm Biopharm, 50:217-220.
12. Movassaghian S, Barzegar-Jalali M, Alaeddini M, Hamedyazdan S, Afzalifar R, Zakeri-Milani P et al. (2011). Development of amitriptyline buccoadhesive tablets for management of pain in dental procedures. Drug Dev Ind Pharm, 37:849-854.
13. Gajdziok J, Bajerová M, Chalupová Z, Rabisková M. (2010). Oxycellulose as mucoadhesive polymer in buccal tablets. Drug Dev Ind Pharm, 36:1115-1130.
14. Surapaneni MS, Das SK, Das NG. (2006). Efect of excipient and processing variables on adhesive properties and release profle of pentoxifylline from mucoadhesive tablets. Drug Dev Ind Pharm, 32:377-387.
15. Carlo Ceschel G, Bergamante V, Calabrese V, Biserni S, Ronchi C, Fini A. (2006). Design and evaluation in vitro of controlled release mucoadhesive tablets containing chlorhexidine. Drug Dev Ind Pharm, 32:53-61.
16. Nafee NA, Ismail FA, Boraie NA, Mortada LM. (2004). Mucoadhesive delivery systems. I. Evaluation of mucoadhesive polymers for buccal tablet formulation. Drug Dev Ind Pharm, 30:985-993.
17. Nafee NA, Ismail FA, Boraie NA, Mortada LM. (2004). Mucoadhesive delivery systems. II. Formulation and in-vitro/in-vivo evaluation of buccal mucoadhesive tablets containing water-soluble drugs. Drug Dev Ind Pharm, 30:995-1004.
18. Adhikary A, Vavia PR. (2008). Bioadhesive ranitidine hydrochloride for gastroretention with controlled microenvironmental pH. Drug Dev Ind Pharm, 34:860-869.
19. Chary RB, Vani G, Rao YM. (1999). In vitro and in vivo adhesion testing of mucoadhesive drug delivery systems. Drug Dev Ind Pharm, 25:685-690.
20. Mandal AS, Chatterjee S, Karim KM, Biswas N, Guha A, Behera M et al. (2012). Fabrication and in vitro evaluation of bidirectional release and stability studies of mucoadhesive donut-shaped captopril tablets. Drug Dev Ind Pharm, 38:706-717.
21. Van Vooren L, Krikilion G, Rosier J, De Spiegelee B. (2001). A novel bending point criterion for dissolution profle interpretation. Drug Dev Ind Pharm, 27:885-892.
22. Suzuki H, Onishi H, Takahashi Y, Iwata M, Machida Y. (2003). Development of oral acetaminophen chewable tablets with inhibited bitter taste. Int J Pharm, 251:123-132.
23. Suzuki H, Onishi H, Hisamatsu S, Masuda K, Takahashi Y, Iwata M et al. (2004). Acetaminophen-containing chewable tablets with suppressed bitterness and improved oral feeling. Int J Pharm, 278:51-61.
24. Krause J, Tommes M, Breitkreutz J. (2009). Immediate release pellets with lipid binders obtained by solvent-free cold extrusion. Eur J Pharm Biopharm, 71:138-144.
25. Porter CJ, Trevaskis NL, Charman WN. (2007). Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs. Nat Rev Drug Discov, 6:231-248.
26. Dahan A, Hofman A. (2008). Rationalizing the selection of oral lipid based drug delivery systems by an in vitro dynamic lipolysis model for improved oral bioavailability of poorly water soluble drugs. J Control Release, 129:1-10.
27. Fell JT, Newton JM. (1970). Determination of tablet strength by the diametral-compression test. J Pharm Sci, 59:688-691.
28. Tao Y, Lu Y, Sun Y, Gu B, Lu W, Pan J. (2009). Development of mucoadhesive microspheres of acyclovir with enhanced bioavailability. Int J Pharm, 378:30-36.
29. Yassin AE, Alanazi FK, El-Badry M, Alsarra IA, Barakat NS, Alanazi FK. (2009). Preparation and characterization of spironolactone-loaded gelucire microparticles using spray-drying technique. Drug Dev Ind Pharm, 35:297-304.
30. Ohara T, Kitamura S, Kitagawa T, Terada K. (2005). Dissolution mechanism of poorly water-soluble drug from extended release solid dispersion system with ethylcellulose and hydroxypropylmethylcellulose. Int J Pharm, 302:95-102.
31. Quinten T, De Beer T, Almeida A, Vlassenbroeck J, Van Hoorebeke L, Remon JP et al. (2011). Development and evaluation of injection-molded sustained-release tablets containing ethylcellulose and polyethylene oxide. Drug Dev Ind Pharm, 37:149-159.
32. Quinten T, Gonnissen Y, Adriaens E, De Beer T, Cnudde V, Masschaele B et al. (2009). Development of injection moulded matrix tablets based on mixtures of ethylcellulose and low-substituted hydroxypropylcellulose. Eur J Pharm Sci, 37:207-216.
33. Yang T, Hussain A, Bai S, Khalil IA, Harashima H, Ahsan F. (2006). Positively charged polyethylenimines enhance nasal absorption of the negatively charged drug, low molecular weight heparin. J Control Release, 115:289-297.
34. Lai HL, Pitt K, Craig DQ. (2010). Characterisation of the thermal properties of ethylcellulose using diferential scanning and quasi-isothermal calorimetric approaches. Int J Pharm, 386:178-184.
35. Sakellariou P, Rowe RC, White EFT. Te thermomechanical properties and glass transition temperatures of some cellulose derivatives used in flm coating. Int J Pharm 1985;27:267-277.
36. Higuchi T. (1961). Rate of release of medicaments from ointment bases containing drugs in suspension. J Pharm Sci, 50:874-875.
37. Crowley KJ, Zograf G. (2003). Te efect of low concentrations of molecularly dispersed poly(vinylpyrrolidone) on indomethacin crystallization from the amorphous state. Pharm Res, 20:1417-1422.
38. Padrela L, de Azevedo EG, Velaga SP. (2012). Powder X-ray difraction method for the quantifcation of cocrystals in the crystallization mixture. Drug Dev Ind Pharm, 38:923-929.